2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Multi Drug Resistant Organisms
1
Meningioma
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Diabetes Mellitus
1
Brain Neoplasms
1
Interventions
Peripheral Blood Stem Cell Transplantation
26
Rituximab
20
Cyclophosphamide
18
fludarabine phosphate
17
Mycophenolic Acid
16
Tacrolimus
14
Cyclosporine
14
Whole-Body Irradiation
12
Filgrastim
11
Therapeutics
10
Psychiatric Rehabilitation
10
Flow Cytometry
10
Etoposide
10
Radiotherapy
8
Polymerase Chain Reaction
8
Methotrexate
8
Busulfan
8
Methylprednisolone
7
Antilymphocyte Serum
7
Cladribine
6
immunotoxin HA22
5
Lenalidomide
5
obinutuzumab
4
Vorinostat
4
Vemurafenib
4
Ondansetron
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
Dexamethasone
4
Cord Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Verapamil
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts